Christian Labenz (C Labenz, Joachim Labenz)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 59

Top Topics

Alcohol Consumption

End Stage Renal Disease

Ejection Fraction

Top Venues

Alimentary pharmacology & therapeutics

Hepatology communications

United European gastroenterology journal

Zeitschrift fur Gastroenterologie

This page only lists publications with an associated author ORCID identifier.

Publications

Eva Maria Schleicher, Simon Johannes Gairing, Darko Castven, Charlotte Sophie Hock, Henrike Dobbermann, Sophia Heinrich, Myriam Meineck, Leonard Kaps, Peter Robert Galle, Julia Weinmann-Menke, Marc Nguyen-Tat, Jens U Marquardt, Christian Labenz
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2. American journal of physiology. Gastrointestinal and liver physiology 326 (5) (2024)
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Elise Jonasson, Sven Danneberg, Philippe Sultanik, Peter Robert Galle, Stefania Gioia, Joachim Labenz, Anna S Lok, Jens Uwe Marquardt, Mette Munk Lauridsen, Patricia P Bloom, Dominique Thabut, Silvia Nardelli, Sara Montagnese, Christian Labenz
PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology communications 8 (5) (2024)
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Elise Jonasson, Sven Danneberg, Philippe Sultanik, Peter Robert Galle, Stefania Gioia, Joachim Labenz, Anna S Lok, Jens Uwe Marquardt, Mette Munk Lauridsen, Patricia P Bloom, Dominique Thabut, Silvia Nardelli, Sara Montagnese, Christian Labenz
PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology communications 8 (5) (2024)
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Elise Jonasson, Sven Danneberg, Philippe Sultanik, Peter Robert Galle, Stefania Gioia, Joachim Labenz, Anna S Lok, Jens Uwe Marquardt, Mette Munk Lauridsen, Patricia P Bloom, Dominique Thabut, Silvia Nardelli, Sara Montagnese, Christian Labenz
PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology communications 8 (5) (2024)
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Elise Jonasson, Sven Danneberg, Philippe Sultanik, Peter Robert Galle, Stefania Gioia, Joachim Labenz, Anna S Lok, Jens Uwe Marquardt, Mette Munk Lauridsen, Patricia P Bloom, Dominique Thabut, Silvia Nardelli, Sara Montagnese, Christian Labenz
PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology communications 8 (5) (2024)
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Elise Jonasson, Sven Danneberg, Philippe Sultanik, Peter Robert Galle, Stefania Gioia, Joachim Labenz, Anna S Lok, Jens Uwe Marquardt, Mette Munk Lauridsen, Patricia P Bloom, Dominique Thabut, Silvia Nardelli, Sara Montagnese, Christian Labenz
PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology communications 8 (5) (2024)
Eva Maria Schleicher, Simon Johannes Gairing, Darko Castven, Charlotte Sophie Hock, Henrike Dobbermann, Sophia Heinrich, Myriam Meineck, Leonard Kaps, Peter Robert Galle, Julia Weinmann-Menke, Marc Nguyen-Tat, Jens U Marquardt, Christian Labenz
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2. American journal of physiology. Gastrointestinal and liver physiology 326 (5) (2024)
Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn Markus Schattenberg
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study. Alimentary pharmacology & therapeutics 59 (10) (2024)
Andreas Kommer, Karel Kostev, Eva Maria Schleicher, Julia Weinmann-Menke, Christian Labenz
Proton pump inhibitor use and bone fractures in patients with chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn Markus Schattenberg
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study. Alimentary pharmacology & therapeutics 59 (10) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal (2024)
Wolfgang Maximilian Kremer, Alexander Schwarz, Markus Schepers, Christian Labenz, Felix Hahn, Visvakanth Sivanathan, Christoph Düber, Peter Robert Galle, Martin Franz Sprinzl
Evaluation of Sonographic Muscle Measurement Using Established Muscle Markers. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Maurice Michel, Michelle Doll, Nastasia Albert, Marc Morgenstern, Andreas Behr, Stefan Maxeiner, Christian Labenz, Peter R Galle, Jörn Markus Schattenberg
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetes. United European gastroenterology journal 12 (1) (2024)
Angelo Armandi, Helena Bespaljko, Alexander Mang, Yvonne Huber, Maurice Michel, Christian Labenz, Peter R Galle, Manjusha Neerukonda, Elisabetta Bugianesi, Detlef Schuppan, Jörn Markus Schattenberg
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept study. Alimentary pharmacology & therapeutics (2024)
Leonard Kaps, Carolina Medina-Montano, Matthias Bros, Stephan Grabbe, Simon Johannes Gairing, Eva M Schleicher, Stephan Gehring, Jörn M Schattenberg, Peter R Galle, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis. Mediators of inflammation 2023 (2023)
Simon Johannes Gairing, Eva M Schleicher, Peter Robert Galle, Christian Labenz
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis. Hepatology communications 7 (4) (2023)
Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Stefania Gioia, Elise Jonasson Nielsen, Sven Danneberg, Anna S Lok, Philippe Sultanik, Peter Robert Galle, Joachim Labenz, Dominique Thabut, Jens Uwe Marquardt, Patricia P Bloom, Mette Munk Lauridsen, Sara Montagnese, Silvia Nardelli, Christian Labenz
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. Journal of internal medicine (2023)
Urs Alexander Fichtner, Anita Arslanow, Harald Binder, Peter Robert Galle, Christian Labenz, Frank Lammert, Julia Ortner, Dominikus Stelzer, Louis Velthuis, Erik Farin
How do (false) positively screened patients experience a screening programme for liver cirrhosis or fibrosis in Germany? A qualitative study. Health expectations : an international journal of public participation in health care and health policy (2023)
Julia Ortner, Reyn Joris Van Ewijk, Louis Velthuis, Christian Labenz, Anita Arslanow, Marcus-Alexander Wörns, Matthias Christian Reichert, Erik Farin-Glattacker, Urs Alexander Fichtner, Dominikus Stelzer, Peter Robert Galle, Frank Lammert
Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35. Zeitschrift fur Gastroenterologie (2023)
Simon Johannes Gairing, Eva M Schleicher, Peter Robert Galle, Christian Labenz
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis. Hepatology communications 7 (4) (2023)
Simon Johannes Gairing, Eva M Schleicher, Peter Robert Galle, Christian Labenz
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis. Hepatology communications 7 (4) (2023)
Simon Johannes Gairing, Eva M Schleicher, Leonard Kaps, Sophia Schulte-Beerbuehl, Kristina Steiner, Christian Labenz, Jörn Markus Schattenberg, Peter R Galle, Marcus-Alexander Wörns, Christian Labenz
Development and evaluation of a virtual reality driving test for patients with cirrhosis. Hepatology communications 7 (11) (2023)
Simon Johannes Gairing, Eva M Schleicher, Peter Robert Galle, Christian Labenz
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis. Hepatology communications 7 (4) (2023)
Michael Nagel, Ruben Westphal, Max Hilscher, Peter Robert Galle, Jörn M Schattenberg, Oliver Schreiner, Christian Labenz, Marcus Alexander Wörns
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment. Medicina (Kaunas, Lithuania) 59 (5) (2023)
Simon Johannes Gairing, Lukas Müller, Roman Kloeckner, Peter R Galle, Christian Labenz
Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives. Alimentary pharmacology & therapeutics 55 (10) (2022)
Eva Maria Schleicher, Simon Johannes Gairing, Peter Robert Galle, Julia Weinmann-Menke, Jörn Markus Schattenberg, Karel Kostev, Christian Labenz
A higher FIB-4 index is associated with an increased incidence of renal failure in the general population. Hepatology communications 6 (12) (2022)
Eva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, Simon Johannes Gairing, Leonard Kaps, Jörn M Schattenberg, Peter Robert Galle, Marcus-Alexander Wörns, Michael Nagel, Julia Weinmann-Menke, Christian Labenz
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis. Clinical and translational gastroenterology 13 (7) (2022)
Simon Johannes Gairing, Peter Robert Galle, Jörn Markus Schattenberg, Karel Kostev, Christian Labenz
Portal vein thrombosis is associated with an increased risk of bone fractures. PloS one 17 (4) (2022)
Leonard Kaps, Eva Maria Schleicher, Carolina Medina Montano, Matthias Bros, Simon Johannes Gairing, Constantin Johannes Ahlbrand, Maurice Michel, Pascal Klimpke, Wolfgang Maximilian Kremer, Stefan Holtz, Simone Cosima Boedecker-Lips, Peter Robert Galle, Daniel Kraus, Jörn M Schattenberg, Christian Labenz, Julia Weinmann-Menke
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF). Journal of clinical medicine 11 (10) (2022)
Simon Johannes Gairing, Julian Anders, Leonard Kaps, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter Robert Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Christian Labenz
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology communications 6 (5) (2022)
Simon Johannes Gairing, Eva Maria Schleicher, Christian Labenz
Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis? Metabolic brain disease (2022)
Christian Labenz, Joachim Labenz, Peter R Galle
Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis? Hepatology (Baltimore, Md.) 75 (4) (2022)
Leonard Kaps, Lejla Lukac, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Simon Johannes Gairing, Peter Robert Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Michael Nagel, Christian Labenz
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Maurice Michel, Christian Labenz, Malena Anders, Alisha Wahl, Lisann Girolstein, Leonard Kaps, Wolfgang M Kremer, Yvonne Huber, Peter R Galle, Martin Sprinzl, Jörn Markus Schattenberg
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIV. Hepatology communications 6 (8) (2022)
Sophia Heinrich, Thomas Austgen, Darko Castven, Moritz Hess, Christian Labenz, Martha Kirstein, Carolin Zimpel, Lena Stockhoff, Benjamin Maasoumy, Bernd Heinrich, Hans Heinrich Wedemeyer, Peter Robert Galle, Harald Binder, Marc Nguyen-Tat, Jens-Uwe Marquardt
Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome. United European gastroenterology journal (2022)
Simon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, Christian Labenz, Felix Darstein, Daniel Grimm, Visvakanth Sivanathan, Arndt Weinmann, Marcus-Alexander Wörns, Roman Kloeckner, Michael B Pitton, Florian Thieringer, Khan Fareed Rahman, Peter Robert Galle, Jörn Markus Schattenberg, Friedrich Förster
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case report. Zeitschrift fur Gastroenterologie (2022)
Ferenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, Arjun Narayan Ajmer Jayaswal, Michael Trauner, Jérôme Boursier, Céline Fournier, Katharina Staufer, Rudolf E Stauber, Elisabetta Bugianesi, Ramy Youne, Silvia Gaia, Monica Lupșor-Platon, Salvatore Petta, Toshihide Shima, Takeshi Okanoue, Sanjiv Mahadeva, Wah-Kheong Chan, Peter J Eddowes, Gideon M Hirschfield, Philip Noel Newsome, Vincent Wai-Sun Wong, Victor de Ledinghen, Jiangao Fan, Feng Shen, Jeremy F Cobbold, Yoshio Sumida, Akira Okajima, Jörn M Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yilmaz, Guruprasad Padur Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine J Ooi, Hirokazu Takahashi, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M Julia Brosnan, Quentin Mark Anstee, Stefan Neubauer, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides, null null
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut (2021)
Marie-Kristin Tilch, Peter R Galle, Jörn M Schattenberg, Karel Kostev, Christian Labenz
Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Christian Labenz, Jörn Markus Schattenberg
Letter: proton pump inhibitor use and bone fracture risk-a mechanistic point of view. Authors' reply. Alimentary pharmacology & therapeutics 53 (5) (2021)
Simon Johannes Gairing, Peter Robert Galle, Jörn Markus Schattenberg, Karel Kostev, Christian Labenz
Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders. Journal of clinical medicine 10 (23) (2021)
Christian Labenz, Karel Kostev, Peter R Galle, Marcus-Alexander Wörns, Joachim Labenz, Christian Tanislav, Charles Christian Adarkwah
Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis. Medicine 99 (50) (2021)
Christian Labenz, Karel Kostev, Peter Robert Galle, Marcus-Alexander Wörns, Jörn M Schattenberg
Prescription rates of common medications in patients with decompensated cirrhosis in Germany. Zeitschrift fur Gastroenterologie (2021)
Leonard Kaps, Katharina Hildebrand, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter R Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Christian Labenz
Risk factors for poorer health literacy in patients with liver cirrhosis. PloS one 16 (7) (2021)
Wolfgang M Kremer, Christian Labenz, Robert Kuchen, Ingo Sagoschen, Marc Bodenstein, Oliver Schreiner, Marcus-Alexander Wörns, Visvakanth Sivanathan, Arndt Weinmann, Peter Robert Galle, Martin Franz Sprinzl
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre study. Journal of cachexia, sarcopenia and muscle (2021)
Christian Labenz, Michael Nagel, Paula Kämper, Sinah Engel, Stefan Bittner, Leonard Kaps, Peter R Galle, Jörn M Schattenberg, Marcus-Alexander Wörns, Felix Lüssi
Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis. Clinical and translational gastroenterology 12 (10) (2021)
Christian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, Marcus-Alexander Wörns, Gerrit Toenges, Arndt Weinmann, Peter R Galle, Martin F Sprinzl
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 68 (6) (2020)
Christian Labenz, Michael Nagel, Wolfgang M Kremer, Max Hilscher, Caroline A Schilling, Gerrit Toenges, Robert Kuchen, Jörn Markus Schattenberg, Peter R Galle, Marcus-Alexander Wörns
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis. Alimentary pharmacology & therapeutics 52 (3) (2020)
Christian Labenz, Marcus-Alexander Wörns
Letter: diabetes mellitus increases the risk of hepatic encephalopathy in patients with cirrhosis-authors' reply. Alimentary pharmacology & therapeutics 52 (7) (2020)
Christian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, Peter R Galle, Jörn Markus Schattenberg, Karel Kostev
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study. Alimentary pharmacology & therapeutics 52 (6) (2020)
Christian Labenz, Jörn M Schattenberg, Marcus-Alexander Wörns, Martin F Sprinzl
Response: Frailty assessment in the COVID-19 pandemic. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 68 (7) (2020)
Christian Labenz, Jörn Markus Schattenberg
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply. Alimentary pharmacology & therapeutics 48 (11-12) (2019)
Christian Labenz, Gerrit Toenges, Yvonne Huber, Michael Nagel, Jens U Marquardt, Jörn M Schattenberg, Peter R Galle, Joachim Labenz, Marcus-Alexander Wörns
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy. Alimentary pharmacology & therapeutics 50 (10) (2019)
Yvonne Huber, Daniel Pfirrmann, Ines Gebhardt, Christian Labenz, Nadine Gehrke, Beate K Straub, Christian Ruckes, Heike Bantel, Eugenio Belda, Karine Clément, Diana J Leeming, Morten A Karsdal, Peter R Galle, Perikles Simon, Jörn Markus Schattenberg
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. Alimentary pharmacology & therapeutics 50 (8) (2019)
Christian Labenz, M-A Wörns
Editorial: covert hepatic encephalopathy-silent but serious. Authors' reply. Alimentary pharmacology & therapeutics 48 (4) (2019)
Christian Labenz, Yvonne Huber, Eva Kalliga, Michael Nagel, Christian Ruckes, Beate K Straub, Peter R Galle, Marcus-Alexander Wörns, Quentin M Anstee, Detlef Schuppan, Jörn Markus Schattenberg
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany. Alimentary pharmacology & therapeutics 48 (10) (2018)
Christian Labenz, J S Baron, G Toenges, J M Schattenberg, M Nagel, M F Sprinzl, M Nguyen-Tat, T Zimmermann, Y Huber, J U Marquardt, P R Galle, M-A Wörns
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients. Alimentary pharmacology & therapeutics 48 (3) (2018)